Neuropsychopharmacology - Table of Contents alert Volume 43 Issue 13

TABLE OF CONTENTS Volume 43, Issue 13 In this issue Research Highlight Perspective Circumspective Review Article Article Correction Also new AOP Research Highlight GSK3β in the prefrontal cortex: a molecular handle specific to addiction pathology? Andrew L. Eagle & A. J. Robison Neuropsychopharmacology 2018 43 :2497 - 2498; October 11, 2018; 10.1038/s41386-018-0224-4 Abstract | Full Text Perspective Digital devices and continuous telemetry: opportunities for aligning psychiatry and neuroscience Justin T. Baker, Laura T. Germine, Kerry J. Ressler, Scott L. Rauch & William A. Carlezon Jr. Neuropsychopharmacology 2018 43 :2499 - 2503; August 02, 2018; 10.1038/s41386-018-0172-z Abstract | Full Text Digital phenotyping approaches and mobile devices enhance CNS biopharmaceutical research and development Daniel G. Smith Neuropsychopharmacology 2018 43 :2504 - 2505; September 18, 2018; 10.1038/s41386-018-0222-6 Abstract | Full Text Circumspective Food addiction: a valid concept? Paul C. Fletcher & Paul J. Kenny Neuropsychopharmacology 2018 43 :2506 - 2513; September 06, 2018; 10.1038/s41386-018-0203-9 Abstract | Full Text Review Article Untangling the complexity of opioid receptor function Rita J. Valentino & Nora D. Volkow Neuropsychopharmacology 2018 43 :2514 - 2520; September 24, 2018; 10.1038/s41386-018-0225-3 Abstract | Full Text Article Glycogen synthase kinase 3 beta regulates ethanol consumption and is a risk factor for alcohol dependence Andrew van der Vaart, Xianfang Meng, M. Scott Bowers, Angela M. Batman, Fazil Aliev et al. Neuropsychopharmacology 2018 43 :2521 - 2531; September 06, 2018; 10.1038/s41386-018-0202-x Abstract | Full Text Striatal activity correlates with stimulant-like effects of alcohol in healthy volunteers Jessica Weafer, Thomas J. Ross, Sean O'Connor, Elliot A. Stein, Harriet de Wit et al. Neuropsychopharmacology 2018 43 :2532 - 2538; August 01, 2018; 10.1038/s41386-018-0166-x Abstract | Full Text PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age Aishwarya Vijay, Dana Cavallo, Alissa Goldberg, Bart de Laat, Nabeel Nabulsi et al. Neuropsychopharmacology 2018 43 :2539 - 2547; September 06, 2018; 10.1038/s41386-018-0199-1 Abstract | Full Text Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder Karen Curtin, Annette E. Fleckenstein, Brooks R. Keeshin, Deborah A. Yurgelun-Todd, Perry F. Renshaw et al. Neuropsychopharmacology 2018 43 :2548 - 2555; September 12, 2018; 10.1038/s41386-018-0207-5 Abstract | Full Text Disentangling the genetic overlap between cholesterol and suicide risk Emma E. M. Knowles, Joanne E. Curran, Peter J. Meikle, Kevin Huynh, Samuel R. Mathias et al. Neuropsychopharmacology 2018 43 :2556 - 2563; July 23, 2018; 10.1038/s41386-018-0162-1 Abstract | Full Text HPA axis response and psychosocial stress as interactive predictors of suicidal ideation and behavior in adolescent females: a multilevel diathesis-stress framework Tory A. Eisenlohr-Moul, Adam B. Miller, Matteo Giletta, Paul D. Hastings, Karen D. Rudolph et al. Neuropsychopharmacology 2018 43 :2564 - 2571; September 06, 2018; 10.1038/s41386-018-0206-6 Abstract | Full Text Response to therapeutic sleep deprivation: a naturalistic study of clinical and genetic factors and post-treatment depressive symptom trajectory Nina Trautmann, Jerome C. Foo, Josef Frank, Stephanie H. Witt, Fabian Streit et al. Neuropsychopharmacology 2018 43 :2572 - 2577; May 17, 2018; 10.1038/s41386-018-0092-y Abstract | Full Text Targeting the affective brain–a randomized controlled trial of real-time fMRI neurofeedback in patients with depression David M. A. Mehler, Moses O. Sokunbi, Isabelle Habes, Kali Barawi, Leena Subramanian et al. Neuropsychopharmacology 2018 43 :2578 - 2585; June 23, 2018; 10.1038/s41386-018-0126-5 Abstract | Full Text Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia Anindya Bhattacharya, Brian Lord, Jan-Sebastian Grigoleit, Yingbo He, Ian Fraser et al. Neuropsychopharmacology 2018 43 :2586 - 2596; July 09, 2018; 10.1038/s41386-018-0141-6 Abstract | Full Text Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling Geoffroy Laumet, Jules Daniel Edralin, Angie Chi-An Chiang, Robert Dantzer, Cobi J. Heijnen et al. Neuropsychopharmacology 2018 43 :2597 - 2605; July 16, 2018; 10.1038/s41386-018-0154-1 Abstract | Full Text The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence Kevin Lee, Helen E. Vuong, David J. Nusbaum, Elaine Y. Hsiao, Christopher J. Evans et al. Neuropsychopharmacology 2018 43 :2606 - 2614; September 10, 2018; 10.1038/s41386-018-0211-9 Abstract | Full Text Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats Jun-Tao Gao, Chloe J. Jordan, Guo-Hua Bi, Yi He, Hong-Ju Yang et al. Neuropsychopharmacology 2018 43 :2615 - 2626; October 03, 2018; 10.1038/s41386-018-0231-5 Abstract | Full Text Unlimited sucrose consumption during adolescence generates a depressive-like phenotype in adulthood Aliou B. Gueye, Leandro F. Vendruscolo, Camila de Ávila, Catherine Le Moine, Muriel Darnaudéry et al. Neuropsychopharmacology 2018 43 :2627 - 2635; February 27, 2018; 10.1038/s41386-018-0025-9 Abstract | Full Text Alteration of BDNF in the medial prefrontal cortex and the ventral hippocampus impairs extinction of avoidance Luis E. Rosas-Vidal, Valeria Lozada-Miranda, Yisel Cantres-Rosario, Alexis Vega-Medina, Loyda Melendez et al. Neuropsychopharmacology 2018 43 :2636 - 2644; August 11, 2018; 10.1038/s41386-018-0176-8 Abstract | Full Text Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans Nikolina Skandali, James B. Rowe, Valerie Voon, Julia B. Deakin, Rudolf N. Cardinal et al. Neuropsychopharmacology 2018 43 :2645 - 2651; September 26, 2018; 10.1038/s41386-018-0229-z Abstract | Full Text Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis Gemma Modinos, Fatma Simsek, Matilda Azis, Matthijs Bossong, Ilaria Bonoldi et al. Neuropsychopharmacology 2018 43 :2652 - 2659; January 30, 2018; 10.1038/s41386-017-0004-6 Abstract | Full Text Correction Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis Gemma Modinos, Fatma Simsek, Matilda Azis, Matthijs Bossong, Ilaria Bonoldi et al. Neuropsychopharmacology 2018 43 :2660 - 2660; October 02, 2018; 10.1038/s41386-018-0118-5 Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. This email has been sent to edgeblog.alerts.2011.001@gmail.com. If you no longer wish to receive the email alerts from Neuropsychopharmacology click here to unsubscribe . If you wish to discontinue all email services from Nature Research please click here to unsubscribe . For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.